Europe won't renew AstraZeneca, Johnson & Johnson COVID-19 vaccine contracts next year: report

Amid delivery delays and concerns over rare but serious blood clots for the AstraZeneca and Johnson & Johnson COVID-19 shots, European officials are looking elsewhere for next year's supply.

The European Commission has opted against renewing its vaccine contracts with AstraZeneca and J&J once they expire at the end of the year, Italian newspaper La Stampa reported Wednesday, citing an unnamed source from the Italian health ministry. Reuters also picked up the story.